ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An update of genetics, co-morbidities and management of hyperuricaemia

Zhu, Chunsheng; Sun, Bao; Zhang, Bing; Zhou, Zheng*郑州大学
Clinical and Experimental Pharmacology and Physiology2021-10DOI: 10.1111/1440-1681.13539
12被引13阅读
引用收藏
分享

摘要

Hyperuricaemia (HU) caused by disorders of purine metabolism is a metabolic disease. A number of epidemiological reports have confirmed that HU is correlated with multiple disorders, such as chronic kidney diseases, cardiovascular disease and gout. Recent studies showed that the expression and functional changes of uric acid transporters, including URAT1, GLUT9 and ABCG2, were associated with HU. Moreover, a large number of genome-wide association studies have shown that these transporters' dysfunction leads to HU. In this review, we describe the recent progress of aetiology and related transporters of HU, and we also summarise the common co-morbidities possible mechanisms, as well as the potential pharmacological and non-pharmacological treatment methods for HU, aiming to provide new ideas for the treatment of HU.

学科与关键词

关键词
co-morbiditieshyperuricaemiaoxidative stresstransportersurate-lowering therapyuric acid
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Clinical and Experimental Pharmacology and Physiology
发表日期
2021-10
卷期
第 48 卷, 第 10 期
页码
1305-1316
DOI
10.1111/1440-1681.13539
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE

作者

  • Z

    Zhu, Chunsheng (第一作者)

    zhengzhou univ

  • S

    Sun, Bao

查看全部 4 位作者收起作者
  • Z

    Zhang, Bing

    beijing univ chinese med

  • Z

    Zhou, Zheng (通讯)

    zhengzhou univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417